A joint meeting of FlowcytometryUK and the RMS.
This is a follow up meeting to the Virtual FlowcytometryUK Facility Meeting to establish safe working practices in the COVID-19 era and the Virtual FlowcytometryUK Open Facilities Forum which took place on 15th May and 12th June respectively.
Organisers: Peter O'Toole, Derek Davies, Rachael Walker, Jessica Back
This meeting will be an open forum and points for discussion will include:
This meeting will take place from 3pm-5pm BST, 10am-12pm ET
Sponsorship opportunities are available for this event, please contact Kate Wooding.
At Luminex, our mission is to empower labs to obtain reliable, timely and actionable answers, ultimately advancing health. We serve the needs of our customers in diverse markets including clinical diagnostics, drug discovery, life science research, immunology, and personalized medicine. Our goal is to transform global healthcare with innovative instruments and assays that deliver cost-effective results to clinicians and researchers. The flexible and open-architecture design of our xMAP® Technology is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics. Our xTAG®, MultiCode® and NanoGrid technologies support a wide range of clinical applications, including infectious disease testing and genetics, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and speed. Our innovative Amnis® and Guava® Flow Cytometers provide complete solutions to advance life science discovery, process quality, and clinical monitoring. Through these technologies and the expertise of Luminex employees worldwide, we envision a Luminex solution in every lab around the world seeking to obtain timely and confident answers.
Find out more about Luminex Corporation
Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyse, and utilize the cell. Our technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like haematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has 2,500 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.
Find out more about Miltenyi Biotec Ltd